Dame June Munro Raine DBE (née Harris; born 1952), is a British doctor who is currently serving as the Chief Executive Officer of the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom.

[1][4] In 1985, Raine joined the Department of Health and Social Security in the Medicines Division, before that function moved to the newly formed MHRA in 2003.

[12] The authorisation drew criticism from EU legislators, who called the MHRA's decision "hasty" and "problematic",[13] and the European Medicines Agency (EMA) issued a statement that a longer approval procedure was needed using more detailed evidence and checks than the EMA's "emergency authorisation" route as chosen by Raine, given the novel nature of the vaccine and the potential scale of its distribution.

Raine said: "This recommendation has only been given by the MHRA, following the most rigorous scientific assessment of every piece of data, so that it meets the required strict standards of safety, of effectiveness, and of quality.

We've also reviewed and agreed the prescribing information, so that the public and health care professionals are very clear and can be very confident that the vaccine is being used in the correct way, understanding what's involved.